CWM
ABBV icon

Cabot Wealth Management’s AbbVie ABBV Stock Holding History

Cabot Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Hold
1,405
– – 0.04% 114
2026
Q1 		$306K Sell
1,405
-301
-18% -$66.8K 0.04% 122
2025
Q4 		$390K Buy
1,706
+241
+16% +$54.9K 0.04% 112
2025
Q3 		$339K Buy
+1,465
New +$298K 0.04% 118

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cabot Wealth Management's ABBV Position: Q2 2026 in Review

Cabot Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,405 shares worth $354K. The position accounts for 0.04% of the portfolio, ranked #114.

Cabot Wealth Management first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. The position peaked at $390K in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cabot Wealth Management held 1,405 shares of AbbVie worth $354K as of Q2 2026.
  • Cabot Wealth Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.04% of Cabot Wealth Management's portfolio in Q2 2026, its #114 holding.
  • Cabot Wealth Management first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • Cabot Wealth Management's AbbVie position peaked at $390K in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cabot Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.